Joining Hands Worldwide to Conquer Cancer

On November 14, 2026, The 8th ASEAN International Oncology Integrative Medicine Session will be held in Changsha, Hunan Province, China. The session will bring together oncology experts and scholars from Southeast Asia, Central Asia, South Asia, Russia, Mongolia, and other countries and regions to share clinical practice and regional cooperation experience on topics including cancer prevention and treatment, integrative oncology medicine, precision diagnosis and treatment, and innovative minimally invasive technologies.

Cancer prevention and treatment is a common challenge facing the world, and integrative medicine provides an important pathway for interdisciplinary and cross-regional collaboration. This forum will build an international academic exchange platform, promote mutual learning and exchange among different countries in oncology prevention and treatment concepts, clinical practice, and medical collaboration, and explore practical directions for integrative oncology medicine in the full-course management of cancer.

As an important participant in international oncology medical exchange and cooperation, Modern Cancer Hospital Guangzhou will continue to promote international medical exchange and integrative diagnosis and treatment practice, join hands with medical colleagues from various countries to promote experience sharing and coordinated development, and explore more diagnosis and treatment approaches and support for cancer patients.

Starting from China, connecting ASEAN, joining hands with the world. On November 14, 2026, let us meet in Changsha, using integration to promote exchange, cooperation to seek development, and jointly build a shared future against cancer.

China Anti-Cancer Association (CACA)

International Association for Holistic Integrative Medicine (IAHIM)

Hunan Anti-Cancer Association

CACA Belt and Road International Training Center (Guangdong) Modern Cancer Hospital Guangzhou

Harnessing ASEAN Anti-Cancer Wisdom to

Advance Integrative Medicine Practice

Professor Dai Wenyan

Head of the Breast Cancer Specialty, Modern Cancer Hospital Guangzhou

Shared the clinical application and exploration of cryotherapy for early-stage breast cancer. She introduced the minimally invasive advantages and indication selection of cryoablation in early-stage breast cancer, emphasizing the need to combine imaging assessment and multidisciplinary collaboration to provide patients with more possibilities for breast-conserving and function-preserving treatment.

Professor Liang Zhao

Physician, Department of Hematology, Zhujiang Hospital of Southern Medical University

He shared the practice and breakthroughs of CAR-T cell therapy in relapsed/refractory hematologic malignancies. Drawing on his team’s experience in end-to-end CAR-T management and combination treatment paradigms, he noted that immunotherapy is significantly improving clinical survival rates in malignant hematologic diseases, and emphasized that standardized management is key to both efficacy and safety.

Professor He Yihan

Associate Researcher and Attending Physician, Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine

She shared the adjunctive role and practice of traditional Chinese medicine (TCM) in integrative oncology. Drawing on clinical and evidence-based research on acupuncture–medication combination therapy for cancer-related symptoms, she discussed the value of TCM in alleviating cancer pain, improving treatment-related adverse effects, and enhancing patients' quality of life. She emphasized that TCM should serve as an important synergistic force within the integrative oncology system rather than a replacement modality.

Professor Zhang Yanling

Senior Experimentalist and Expert in Tumor Particle Therapy Research, Southern Medical University

She shared research progress and translational perspectives on minimally invasive particle therapy in integrative oncology. Drawing on her exploration of iodine-125 (¹²⁵I) seed brachytherapy for liver cancer and mechanisms of radioresistance, she discussed how to optimize the precision and efficacy of particle therapy through basic research, providing an experimental basis for the synergy between minimally invasive intervention and radiotherapy.

Professor Nie Runcong

Associate Chief Physician, Department of Gastric Surgery, Sun Yat-sen University Cancer Center

He shared the integrated clinical application of minimally invasive surgery and immuno-targeted therapy for gastric cancer. Drawing on the Department of Gastric Surgery's experience with robotic/laparoscopic radical gastrectomy and perioperative immunotherapy, he noted that the synergy between minimally invasive techniques and precision immunotherapy can help improve patient prognosis and quality of life while ensuring radical treatment outcomes.

Dr. Chua Hui Ming

Senior Principal Assistant Director, National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health, Malaysia

Shared the regulatory evolution of biological products and biosimilars in Malaysia from the perspective of regulatory science. She pointed out that establishing a scientific, transparent, and internationally aligned review and approval system is key to ensuring the sustainable and accessible nature of oncology treatment, and emphasized that regulatory policies need to work in coordination with clinical practice.

Dr. Samat Nurlanovich Kaldarbekov

Executive Director, Kazakhstan Cancer Society (KazCS)

Shared Kazakhstan's exploration in the field of early lung cancer screening. He introduced the country's pathway and management experience in promoting the construction of a national-level screening program relying on low-dose spiral CT, and emphasized that the sustainable operation of the screening system requires coordinated support from policy, technology, and grassroots capacity.

Dr. Antonova Svetlana

Nuclear Medicine Physician, Nuclear Medicine Institute, "Medicine" JSC, Russia

Shared the application of targeted radionuclide therapy in prostate cancer with bone metastases. From the two levels of molecular basis and clinical practice, she analyzed the principles and efficacy of this therapy, and discussed the development prospects of nuclear medicine in precision oncology treatment.

Dr. TRAN HUU HIEN

School of Biomedical Engineering, Vietnam National University Ho Chi Minh City, EASL Member

Shared that the application of machine learning in the field of liver cancer is moving from a boom toward evidence-based practice. Based on research evidence from top journals in recent years, he reviewed the actual value and limitations of machine learning in liver cancer diagnosis and treatment, and emphasized the need to promote the standardized implementation of technology based on evidence-based medicine.

Dr. GOLAM MOHIUDDIN FARUQUE

President and Program Director, Bangladesh Cancer Society

Shared the current status and future plans of Bangladesh's cancer prevention and treatment strategy. Based on current prevention and treatment challenges, he looked ahead to the direction of future system development, emphasized the need to advance cancer prevention and control in light of the country's actual conditions, and called for strengthened regional cooperation to enhance overall prevention and treatment capacity.

Dr. dr. Handoko, B.Med. Sci, Sp.Onk.Rad., Subsp.T.P.L. (K)

Indonesian Radiation Oncologist

He shared practical strategies for mutation–drug matching in real-world clinical practice. Drawing on the Indonesian context, he explained how to translate genetic testing results into actionable medication decisions, emphasizing that under resource constraints it is necessary to balance evidence-based considerations with patient access, thereby providing a pragmatic pathway for the implementation of precision medicine.

Chinese and Foreign Experts Gather to

Empower and Lead Integrative Medicine Forward

Fan Daiming

The Council Chairman of China Anti-Cancer Association | the Academician of Chinese Academy of Engineering

Specialty: Prof. Fan Daiming has long been engaged in the basic and clinical research of digestive diseases. Specifically, he has made great contributions to the molecular mechanism, control and prevention of the occurrence and development of gastric cancer.

Wang Ying

Expert of Belt and Road Holistic Integrative Oncology Training Base (Guangdong) of CACA | Associate Professor

Specialty: Prof. Wang has engaged in clinical practices and research of oncology for over 10 years, specialized in immunotherapy, targeted drugs, chemotherapy and management of toxic side efforts from treatments , cancer pain treatment, long-term survival guidance and management for patients with gastrointestinal tumors, such as colon-rectal cancer, gastric cancer, liver cancer, and esophageal cancer. She had participated in multiple international and domestic multi-center clinical trials of new anti-tumor

Jiang Haiping

Professor & Doctoral supervisor | Chief physician

Specialty: He is good at the diagnosis and treatment of gastric cancer, colorectal cancer, thyroid disease, external abdominal hernia, anorectal disease, anal preservation operation for low rectal cancer, total mesenteric resection and malnutrition caused by var

Zhang Fujun

Consultant of St. Stamford Modern Cancer Hospital Guangzhou | Chief Physician

Specialty: Introduction: Oncologist, Chief Physician, Professor, Doctoral Supervisor Expert of Belt and Road Holistic Integrative Oncology Training Base of CACA He works as Chief Physician of Sun Yat-sen University Cancer Center, Deputy Director of Radiological

Chen Xiaobing

Experts of Belt and Road Holistic Integrative Oncology Training Base（Guangdong） of CACA. | Chief physician

Specialty: He specializes in standardized precision treatment of gastric cancer, esophageal cancer, colorectal cancer, liver cancer and other gastrointestinal tumors and lung cancer, breast cancer and etc. He also has rich clinical experience in cancer pain mana

Wang Xiaoxiao

Experts of Belt and Road Holistic Integrative Oncology Training Base(Guangdong) of CACA | Associate Chief Physician

Specialty: Introduction: Associate Chief Physician, Master of Medicine. A committee member of Lymphoma Professional Committee of China Anti-Cancer Association, member of Tumor Clinical Chemotherapy Professional Committee of China Anti-Cancer Association, member of Hematology Oncology Professional Committee of Guangdong Anti-cancer Association, member of Lymphoma Professional Committee of Guangdong Anti-cancer Association, standing member of Hematology Oncology Professional Committee of Guangdong Preventive

Xia Wen

Experts of Belt and Road Holistic Integrative Oncology Training Base(Guangdong) of CACA | Associate Chief Physician

Specialty: Dr. Xia is good at individualized breast cancer treatment and whole course management (chemical treatment, endocrine therapy and targeted therapy), breast benign and malignant tumors, breast disease screening, genetic counseling and whole course management.

Professor Song Shijun

ASEAN International Minimally Invasive Oncology Expert

Chief Oncology Expert, Modern Cancer Hospital Guangzhou

“Tailoring life plans for patients is a doctor's lifelong duty.”

Professor Song Shijun brings over 40 years of clinical oncology experience. He is a senior member of the Chinese Society of Clinical Oncology (CSCO), the American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO), and has long been active on the frontlines of medical exchange between China and Southeast Asia.

Specializes in chemotherapy, targeted therapy, and minimally invasive therapy for various solid tumors. Particularly experienced in lung cancer, breast cancer, esophageal cancer, and colorectal cancer, with extensive experience in diagnosing and treating clinically challenging malignant tumors. Has treated over ten thousand patients from China and abroad, significantly extending the survival of many patients with advanced-stage cancer.

Dialogue with ASEAN Oncology Experts

Professor Dai Wenyan

ASEAN International Minimally Invasive Oncology Expert

Head of the Breast Cancer Department, Modern Cancer Hospital Guangzhou

“Every promotion is not just an honor, but also a responsibility.”

Professor Dai Wenyan has dedicated over two decades to the field of minimally invasive oncology and personalized treatment. She currently holds key positions in multiple national and international oncology professional committees, including serving as a standing committee member of the Individualized Therapy Expert Committee of the Chinese Anti-Cancer Association and a committee member of the Particle Therapy Committee of the Chinese Anti-Cancer Association.

After furthering her studies at the National Cancer Centre Singapore, Professor Dai Wenyan introduced the concept of “patient-centered, whole-process management” into the development of the breast cancer department. She established and led a team to create a precision diagnosis and treatment system centered around minimally invasive techniques and supported by integrated therapies, offering more survival opportunities for patients with advanced-stage breast cancer.

Dialogue with ASEAN Oncology Experts

Professor Ma Xiaoying

ASEAN International Minimally Invasive Oncology Expert

Expert in Minimally Invasive Oncology, Modern Cancer Hospital Guangzhou

“Medicine is not merely about curing diseases; it is an art related to the quality of life.”

Professor Ma Xiaoying is an internationally renowned expert in minimally invasive oncology. She serves as a committee member of the Medical Oncology and Endoscopic Oncology Committees of the Chinese Anti-Cancer Association. With over two decades of clinical experience in oncology, she has treated more than 5,000 cross-border patients from Southeast Asia.

She excels in chemotherapy, targeted therapy, and immunotherapy for solid tumors such as lung cancer, gastrointestinal, gynecological, and genitourinary cancers. In particular, she specializes in minimally invasive comprehensive treatment plans for advanced-stage and refractory tumors. Her team has completed over a thousand minimally invasive surgeries, significantly prolonging patients’ survival periods. They consistently adhere to the treatment philosophy of “improving therapeutic effects and alleviating pain.”

Dialogue with ASEAN Oncology Experts

Professor Wang Baoli

ASEAN’s International Experts in Minimally Invasive Oncology

Minimally Invasive Oncology Specialist of Modern Cancer Hospital Guangzhou

“Medicine: Not Just a Science, But a Reverence for Life”

Dr. Wang Baoli boasts nearly two decades of clinical experience, specializing in comprehensive minimally invasive interventions, chemotherapy, and combined targeted immunotherapy for complex cancers including liver, lung, gastric, colorectal, and ovarian cancers.

He champions a comprehensive care model centered on Multidisciplinary Team (MDT) collaboration and precision personalized therapy, delivering treatment plans with a dual commitment to therapeutic efficacy and quality of life.

Dialogue with ASEAN Oncology Experts

ASEAN Expert Consultation Appointment Zone

Do you also want ASEAN oncology experts to evaluate your condition?

We provide you with direct access to experts:

1. Book an ASEAN expert consultation: Obtain a one-on-one professional second opinion.

2. Watch the ASEAN Forum together: Get direct access to cutting-edge oncology treatment advances.

Fill in the Form, Book Now!

Patient's Name

Cancer type

Phone number

Country

Medical reports

Yes No

Upload reports (optional)

Technological Innovation in Treatment Models

Minimally Invasive Achievements in Anti-Cancer Breakthroughs

Radiofrequency Ablation

Liver cancer, lung cancer, breast cancer and other metastatic tumor

Interventional Therapy

Mainly used in liver cancer, lung cancer, breast cancer, colorectal cancer, cervical cancer, nasopharyngeal cancer, thyroid cancer, prostate cancer, gastric cancer and other solid tumors.

Cryotherapy

Liver cancer, lung cancer, breast cancer, colon cancer, cervical cancer, nasopharyngeal cancer, thyroid cancer, prostate cancer, stomach cancer and other solid tumor

Combined Knife

Liver cancer, lung cancer, pancreatic cancer, thyroid cancer, prostate cancer, kidney cancer, adrenal tumor and primary and metastatic solid tumors in various organs such as abdominal and pelvic tumor

Nanoknife Technology

Pancreatic cancer, liver cancer, lung cancer, kidney cancer, prostate cancer and other solid tumors, especially for tumors near the hilar area, gallbladder, bile duct, pancreas, and ureter

Academician Fan Daiming

President of the Chinese Anti-Cancer Association (CACA)

Professor Wang Ying

Secretary-General of the Chinese Anti-Cancer Association (CACA)

Professor Zhang Fujun

Director of the CACA Belt and Road International Training Co-establishing Institution (Guangdong)

Ben Perkasa Drajat

Consul General of Indonesia in Guangzhou

Phạm Chí Cường

Consul of the Vietnamese Consulate General in Guangzhou

Abu Khaled Muhammad lqba

Head of Surgical Oncology, National Cancer Institute and Hospital (NICRH)

Chris Cheng Yuong Kang

President, Sarawak Cancer Society (Malaysia)

Professor Dai Wenyan

Head of the Breast Cancer Specialty, Modern Cancer Hospital Guangzhou

Professor Wang Baoli

Minimally Invasive Oncology Expert, Modern Cancer Hospital Guangzhou

Professor Wang Ligen

Director of the International Medical Exchange Center, Modern Cancer Hospital Guangzhou

Professor Huang Zuoping

International Integrative Oncology Specialist, Modern Cancer Hospital Guangzhou

Professor He Jianyu

Global Specialist in Minimally Invasive Oncology, Modern Cancer Hospital Guangzhou

Dr. fahmi radityamurti sp onk rad

Head of Radiation Oncology, Indonesian Public Hospital

Saktaganov Muratzhan

Breast Cancer Specialist, National Cancer Center of Kazakhstan

Lê Công Định

Deputy Head, Palliative Care Department, Hanoi Oncology Hospital, Vietnam

PGS. TS. Nguyễn Trung Chính

Director of Oriental General Hospital

Highlights of Past ASEAN Sessions

ICCF Indonesia-China Forum Summit. The 7th ASEAN International Oncology Integrative Medicine Session

Joining Global Forces to Build a Shared Future Against Cancer — The 6th ASEAN International Oncology Integrative Medicine Session

Cancer Care: Winning Through Integration | The 5th ASEAN International Integrative Oncology Forum - Malaysia

Cancer Care: Where Integration Saves Lives | The 5th ASEAN International Integrative Oncology Forum - Hanoi, Vietnam

Winning in Cancer Treatment Through Integration: The 3rd ASEAN International Integrated Oncology Medicine Session

Putting Integrated Medicine into Practice, Joining Hands Across Borders to Fight Cancer: The 2nd ASEAN International Integrated Oncology Medicine Session

Winning in Cancer Treatment Through Integration: The 1st ASEAN International Integrated Oncology Medicine Session

China Anti-Cancer Association Integrated Oncology Medicine Training Base settled in Guangdong

Since the launch of the first ASEAN International Oncology Integrative Medicine Session in 2020, seven sessions have been successfully held, becoming an important platform for the exchange of cross-border anti-cancer experience, technology, and concepts. We have witnessed:

More than 200 oncology experts and scholars from five ASEAN countries gathered for in-depth online and offline exchanges;

Formed a trinity cooperation mechanism of "remote assessment + academic dialogue + joint medical rounds," creating a "borderless cancer rescue chain";

Tens of thousands of patients with intermediate and advanced cancer established contact with ASEAN oncology experts through the forum platform and successfully obtained effective treatment.

As one of the representatives of global integrative oncology treatment, Modern Cancer Hospital Guangzhou continues to serve patients from Southeast Asia, South Asia, Central Asia, Russia, and other countries and regions, helping Chinese cancer technology"go global"and striving for more opportunities for patients to "fight cancer without surgery."

ASEAN Integrative Oncology Forum Highlights

Joining Hands Worldwide to Conquer Cancer

Harnessing ASEAN Anti-Cancer Wisdom to Advance Integrative Medicine Practice

Chinese and Foreign Experts Gather to Empower and Lead Integrative Medicine Forward

ASEAN Expert Consultation Appointment Zone

Technological Innovation in Treatment Models Minimally Invasive Achievements in Anti-Cancer Breakthroughs

Footprints of Progress · Past Experts Together Composing Academic Brilliance

Highlights of Past ASEAN Sessions

ASEAN Integrative Oncology Forum Highlights

Harnessing ASEAN Anti-Cancer Wisdom to

Advance Integrative Medicine Practice

Chinese and Foreign Experts Gather to

Empower and Lead Integrative Medicine Forward

Technological Innovation in Treatment Models

Minimally Invasive Achievements in Anti-Cancer Breakthroughs

Footprints of Progress · Past Experts

Together Composing Academic Brilliance